Analysts Anticipate Humana Inc. (NYSE:HUM) Will Post Earnings of $6.79 Per Share

Analysts predict that Humana Inc. (NYSE:HUMGet Rating) will announce earnings per share (EPS) of $6.79 for the current quarter, according to Zacks. Eight analysts have made estimates for Humana’s earnings, with estimates ranging from $6.59 to $6.99. Humana posted earnings per share of $7.67 in the same quarter last year, which would indicate a negative year-over-year growth rate of 11.5%. The firm is scheduled to announce its next quarterly earnings report before the market opens on Monday, January 1st.

According to Zacks, analysts expect that Humana will report full year earnings of $24.13 per share for the current year, with EPS estimates ranging from $24.01 to $24.32. For the next fiscal year, analysts anticipate that the firm will post earnings of $27.70 per share, with EPS estimates ranging from $26.41 to $31.41. Zacks Investment Research’s EPS calculations are an average based on a survey of research firms that follow Humana.

Humana (NYSE:HUMGet Rating) last announced its earnings results on Wednesday, February 2nd. The insurance provider reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.01. Humana had a return on equity of 17.39% and a net margin of 3.53%. The firm had revenue of $21.05 billion during the quarter, compared to the consensus estimate of $21.28 billion. During the same quarter in the prior year, the company earned ($2.30) EPS. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year.

HUM has been the subject of several recent analyst reports. Barclays decreased their target price on Humana from $540.00 to $490.00 and set an “overweight” rating for the company in a research note on Friday, January 7th. Truist Financial increased their target price on Humana from $460.00 to $490.00 in a research note on Thursday, April 7th. UBS Group upgraded Humana from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $486.00 to $520.00 in a research report on Wednesday. Zacks Investment Research upgraded Humana from a “sell” rating to a “hold” rating and set a $445.00 price objective for the company in a research report on Friday, February 4th. Finally, BMO Capital Markets reduced their price objective on Humana from $490.00 to $415.00 in a research report on Friday, January 7th. Seven equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $484.55.

NYSE:HUM traded up $1.78 during mid-day trading on Friday, hitting $460.56. 1,602,537 shares of the company’s stock traded hands, compared to its average volume of 1,031,613. The firm has a 50 day moving average of $436.03 and a two-hundred day moving average of $431.66. Humana has a 12 month low of $351.20 and a 12 month high of $475.44. The firm has a market capitalization of $58.37 billion, a price-to-earnings ratio of 20.32, a price-to-earnings-growth ratio of 1.40 and a beta of 0.94. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.65.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 29th. Investors of record on Thursday, March 31st will be issued a dividend of $0.7875 per share. This represents a $3.15 dividend on an annualized basis and a yield of 0.68%. This is a boost from Humana’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Wednesday, March 30th. Humana’s dividend payout ratio (DPR) is currently 13.90%.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. Viking Global Investors LP increased its stake in shares of Humana by 411.2% in the 3rd quarter. Viking Global Investors LP now owns 3,007,133 shares of the insurance provider’s stock valued at $1,170,226,000 after buying an additional 2,418,848 shares during the period. Capital Research Global Investors increased its stake in shares of Humana by 49.5% in the 4th quarter. Capital Research Global Investors now owns 3,872,000 shares of the insurance provider’s stock valued at $1,796,075,000 after buying an additional 1,281,466 shares during the period. Norges Bank acquired a new stake in shares of Humana in the 4th quarter valued at $563,554,000. GQG Partners LLC increased its stake in shares of Humana by 86,541.6% in the 4th quarter. GQG Partners LLC now owns 1,139,337 shares of the insurance provider’s stock valued at $528,420,000 after buying an additional 1,138,022 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of Humana by 1,353.7% in the 4th quarter. American Century Companies Inc. now owns 830,312 shares of the insurance provider’s stock valued at $385,148,000 after buying an additional 773,194 shares during the period. 92.96% of the stock is owned by institutional investors.

Humana Company Profile (Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Get a free copy of the Zacks research report on Humana (HUM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.